Skip to main content

Taylor Stacy L's Form 4 filing

Adaptive Biotechnologies Corp (ADPT) · filed Dec 23, 2021

Accession no.
0001209191-21-071194
Filed
Dec 23, 2021
Trade date
Dec 22, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $460.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Taylor Stacy LCIK 0001799081Officer (SVP and General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 22, 2021Common StockMOption exerciseAcquired+10,130$6.55+$66,351.525,166Direct
Dec 22, 2021Common StockMOption exerciseAcquired+5,208$7.80+$40,622.430,374Direct
Dec 22, 2021Common StockSSaleDisposed−15,338$30.00−$460,14015,036Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 22, 2021Common StockMOption exerciseDisposed−10,130$0.00$05,313Direct
Dec 22, 2021Common StockMOption exerciseDisposed−5,208$0.00$017,709Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)